HEADER TRANSFERASE 15-MAY-12 4AUA TITLE LIGANDED X-RAY CRYSTAL STRUCTURE OF CYCLIN DEPENDENT KINASE 6 (CDK6) COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYCLIN-DEPENDENT KINASE 6; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN, RESIDUES 1-301; COMPND 5 SYNONYM: CELL DIVISION PROTEIN KINASE 6, SERINE/THREONINE-PROTEIN COMPND 6 KINASE PLSTIRE; COMPND 7 EC: 2.7.11.22; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR Y.S.CHO,H.ANGOVE,C.BRAIN,C.H.T.CHEN,R.CHENG,R.CHOPRA,K.CHUNG, AUTHOR 2 M.CONGREVE,C.DAGOSTIN,D.DAVIS,R.FELTELL,J.GIRALDES,S.HISCOCK,S.KIM, AUTHOR 3 S.KOVATS,B.LAGU,K.LEWRY,A.LOO,Y.LU,M.LUZZIO,W.MANIARA,R.MCMENAMIN, AUTHOR 4 P.MORTENSON,R.BENNING,M.O'REILLY,D.REES,J.SHEN,T.SMITH,Y.WANG, AUTHOR 5 G.WILLIAMS,A.WOOLFORD,W.WRONA,M.XU,F.YANG,S.HOWARD REVDAT 5 08-MAY-24 4AUA 1 REMARK REVDAT 4 03-APR-19 4AUA 1 REMARK REVDAT 3 07-FEB-18 4AUA 1 AUTHOR JRNL REVDAT 2 18-JUN-14 4AUA 1 JRNL REVDAT 1 06-FEB-13 4AUA 0 JRNL AUTH Y.S.CHO,H.ANGOVE,C.BRAIN,C.H.CHEN,H.CHENG,R.CHENG,R.CHOPRA, JRNL AUTH 2 K.CHUNG,M.CONGREVE,C.DAGOSTIN,D.J.DAVIS,R.FELTELL, JRNL AUTH 3 J.GIRALDES,S.D.HISCOCK,S.KIM,S.KOVATS,B.LAGU,K.LEWRY,A.LOO, JRNL AUTH 4 Y.LU,M.LUZZIO,W.MANIARA,R.MCMENAMIN,P.N.MORTENSON,R.BENNING, JRNL AUTH 5 M.O'REILLY,D.C.REES,J.SHEN,T.SMITH,Y.WANG,G.WILLIAMS, JRNL AUTH 6 A.J.WOOLFORD,W.WRONA,M.XU,F.YANG,S.HOWARD JRNL TITL FRAGMENT-BASED DISCOVERY OF 7-AZABENZIMIDAZOLES AS POTENT, JRNL TITL 2 HIGHLY SELECTIVE, AND ORALLY ACTIVE CDK4/6 INHIBITORS. JRNL REF ACS MED CHEM LETT V. 3 445 2012 JRNL REFN ISSN 1948-5875 JRNL PMID 24900493 JRNL DOI 10.1021/ML200241A REMARK 2 REMARK 2 RESOLUTION. 2.31 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019G REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.31 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 71.23 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 3 NUMBER OF REFLECTIONS : 12395 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.210 REMARK 3 R VALUE (WORKING SET) : 0.207 REMARK 3 FREE R VALUE : 0.277 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 680 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.31 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.37 REMARK 3 REFLECTION IN BIN (WORKING SET) : 884 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.64 REMARK 3 BIN R VALUE (WORKING SET) : 0.2920 REMARK 3 BIN FREE R VALUE SET COUNT : 60 REMARK 3 BIN FREE R VALUE : 0.4280 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2048 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 16 REMARK 3 SOLVENT ATOMS : 86 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.95 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.42000 REMARK 3 B22 (A**2) : 2.42000 REMARK 3 B33 (A**2) : -4.83000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.369 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.274 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.238 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 9.961 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.949 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.911 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2110 ; 0.011 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1466 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2853 ; 1.354 ; 1.967 REMARK 3 BOND ANGLES OTHERS (DEGREES): 3557 ; 0.948 ; 2.993 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 251 ; 6.243 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 98 ;34.838 ;23.469 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 366 ;18.916 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 16 ;17.102 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 319 ; 0.079 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2294 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 440 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 485 ; 0.211 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 1521 ; 0.201 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1025 ; 0.180 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 1085 ; 0.090 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 31 ; 0.152 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): 1 ; 0.025 ; 0.200 REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 11 ; 0.130 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 29 ; 0.249 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 3 ; 0.059 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1274 ; 0.037 ; 5.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 512 ; 0.013 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2060 ; 0.057 ; 6.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 836 ; 0.047 ; 6.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 793 ; 0.063 ; 7.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 4AUA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 15-MAY-12. REMARK 100 THE DEPOSITION ID IS D_1290052506. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9611 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13277 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 71.230 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.04000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.36 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.6 REMARK 200 DATA REDUNDANCY IN SHELL : 3.80 REMARK 200 R MERGE FOR SHELL (I) : 0.37000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.68 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.18 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 5MG/ML 0.1 M MES/NAOH PH 5.7,, 4.5% REMARK 280 W/V PEG 3350, 25 MM SODIUM NITRATE, 10% V/V GLYCEROL, 10 DEGREES REMARK 280 CELSIUS, TEMPERATURE 287K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 4 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y,X,Z REMARK 290 4555 Y,-X,Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -Y+1/2,X+1/2,Z+1/2 REMARK 290 8555 Y+1/2,-X+1/2,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 50.36700 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 50.36700 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 30.15000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 50.36700 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 50.36700 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 30.15000 REMARK 290 SMTRY1 7 0.000000 -1.000000 0.000000 50.36700 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 50.36700 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 30.15000 REMARK 290 SMTRY1 8 0.000000 1.000000 0.000000 50.36700 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 50.36700 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 30.15000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLU A 2 REMARK 465 LYS A 3 REMARK 465 ASP A 4 REMARK 465 GLY A 5 REMARK 465 LEU A 6 REMARK 465 CYS A 7 REMARK 465 ARG A 8 REMARK 465 ALA A 9 REMARK 465 ASP A 10 REMARK 465 TYR A 24 REMARK 465 VAL A 45 REMARK 465 ARG A 46 REMARK 465 VAL A 47 REMARK 465 GLN A 48 REMARK 465 THR A 49 REMARK 465 GLY A 50 REMARK 465 GLU A 51 REMARK 465 GLU A 52 REMARK 465 GLY A 53 REMARK 465 MET A 54 REMARK 465 PRO A 55 REMARK 465 LEU A 56 REMARK 465 VAL A 85 REMARK 465 SER A 86 REMARK 465 ARG A 87 REMARK 465 THR A 88 REMARK 465 ASP A 89 REMARK 465 ARG A 90 REMARK 465 GLU A 91 REMARK 465 THR A 92 REMARK 465 ARG A 168 REMARK 465 ILE A 169 REMARK 465 TYR A 170 REMARK 465 SER A 171 REMARK 465 PHE A 172 REMARK 465 GLN A 173 REMARK 465 MET A 174 REMARK 465 ALA A 175 REMARK 465 LEU A 176 REMARK 465 THR A 177 REMARK 465 SER A 178 REMARK 465 VAL A 179 REMARK 465 VAL A 180 REMARK 465 VAL A 181 REMARK 465 HIS A 302 REMARK 465 HIS A 303 REMARK 465 HIS A 304 REMARK 465 HIS A 305 REMARK 465 HIS A 306 REMARK 465 HIS A 307 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 2078 O HOH A 2081 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 16 -35.50 -138.14 REMARK 500 ASN A 35 68.68 -107.38 REMARK 500 GLU A 72 58.68 28.70 REMARK 500 ARG A 140 50.84 37.47 REMARK 500 ARG A 144 -16.23 77.48 REMARK 500 ASP A 145 53.46 -142.00 REMARK 500 ALA A 197 -176.77 -69.50 REMARK 500 LYS A 257 -82.23 -1.31 REMARK 500 VAL A 266 78.88 -115.62 REMARK 500 ASP A 268 -27.12 106.49 REMARK 500 LEU A 281 43.83 -93.76 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 4AU A 1302 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1BI7 RELATED DB: PDB REMARK 900 MECHANISM OF G1 CYCLIN DEPENDENT KINASE INHIBITION FROM THE REMARK 900 STRUCTURE OF THE CDK6-P16INK4A TUMOR SUPPRESSOR COMPLEX REMARK 900 RELATED ID: 1BI8 RELATED DB: PDB REMARK 900 MECHANISM OF G1 CYCLIN DEPENDENT KINASE INHIBITION FROM THE REMARK 900 STRUCTURES CDK6-P19INK4D INHIBITOR COMPLEX REMARK 900 RELATED ID: 1BLX RELATED DB: PDB REMARK 900 P19INK4D/CDK6 COMPLEX REMARK 900 RELATED ID: 1G3N RELATED DB: PDB REMARK 900 STRUCTURE OF A P18(INK4C)-CDK6-K-CYCLIN TERNARY COMPLEX REMARK 900 RELATED ID: 1JOW RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A COMPLEX OF HUMAN CDK6 AND A VIRALCYCLIN REMARK 900 RELATED ID: 1XO2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A HUMAN CYCLIN-DEPENDENT KINASE 6COMPLEX WITH REMARK 900 A FLAVONOL INHIBITOR, FISETIN REMARK 900 RELATED ID: 2EUF RELATED DB: PDB REMARK 900 X-RAY STRUCTURE OF HUMAN CDK6-VCYCLIN IN COMPLEX WITH THEINHIBITOR REMARK 900 PD0332991 REMARK 900 RELATED ID: 2F2C RELATED DB: PDB REMARK 900 X-RAY STRUCTURE OF HUMAN CDK6-VCYCLINWITH THE REMARK 900 INHIBITORAMINOPURVALANOL DBREF 4AUA A 1 301 UNP Q00534 CDK6_HUMAN 1 301 SEQADV 4AUA HIS A 302 UNP Q00534 EXPRESSION TAG SEQADV 4AUA HIS A 303 UNP Q00534 EXPRESSION TAG SEQADV 4AUA HIS A 304 UNP Q00534 EXPRESSION TAG SEQADV 4AUA HIS A 305 UNP Q00534 EXPRESSION TAG SEQADV 4AUA HIS A 306 UNP Q00534 EXPRESSION TAG SEQADV 4AUA HIS A 307 UNP Q00534 EXPRESSION TAG SEQRES 1 A 307 MET GLU LYS ASP GLY LEU CYS ARG ALA ASP GLN GLN TYR SEQRES 2 A 307 GLU CYS VAL ALA GLU ILE GLY GLU GLY ALA TYR GLY LYS SEQRES 3 A 307 VAL PHE LYS ALA ARG ASP LEU LYS ASN GLY GLY ARG PHE SEQRES 4 A 307 VAL ALA LEU LYS ARG VAL ARG VAL GLN THR GLY GLU GLU SEQRES 5 A 307 GLY MET PRO LEU SER THR ILE ARG GLU VAL ALA VAL LEU SEQRES 6 A 307 ARG HIS LEU GLU THR PHE GLU HIS PRO ASN VAL VAL ARG SEQRES 7 A 307 LEU PHE ASP VAL CYS THR VAL SER ARG THR ASP ARG GLU SEQRES 8 A 307 THR LYS LEU THR LEU VAL PHE GLU HIS VAL ASP GLN ASP SEQRES 9 A 307 LEU THR THR TYR LEU ASP LYS VAL PRO GLU PRO GLY VAL SEQRES 10 A 307 PRO THR GLU THR ILE LYS ASP MET MET PHE GLN LEU LEU SEQRES 11 A 307 ARG GLY LEU ASP PHE LEU HIS SER HIS ARG VAL VAL HIS SEQRES 12 A 307 ARG ASP LEU LYS PRO GLN ASN ILE LEU VAL THR SER SER SEQRES 13 A 307 GLY GLN ILE LYS LEU ALA ASP PHE GLY LEU ALA ARG ILE SEQRES 14 A 307 TYR SER PHE GLN MET ALA LEU THR SER VAL VAL VAL THR SEQRES 15 A 307 LEU TRP TYR ARG ALA PRO GLU VAL LEU LEU GLN SER SER SEQRES 16 A 307 TYR ALA THR PRO VAL ASP LEU TRP SER VAL GLY CYS ILE SEQRES 17 A 307 PHE ALA GLU MET PHE ARG ARG LYS PRO LEU PHE ARG GLY SEQRES 18 A 307 SER SER ASP VAL ASP GLN LEU GLY LYS ILE LEU ASP VAL SEQRES 19 A 307 ILE GLY LEU PRO GLY GLU GLU ASP TRP PRO ARG ASP VAL SEQRES 20 A 307 ALA LEU PRO ARG GLN ALA PHE HIS SER LYS SER ALA GLN SEQRES 21 A 307 PRO ILE GLU LYS PHE VAL THR ASP ILE ASP GLU LEU GLY SEQRES 22 A 307 LYS ASP LEU LEU LEU LYS CYS LEU THR PHE ASN PRO ALA SEQRES 23 A 307 LYS ARG ILE SER ALA TYR SER ALA LEU SER HIS PRO TYR SEQRES 24 A 307 PHE GLN HIS HIS HIS HIS HIS HIS HET 4AU A1302 25 HETNAM 4AU 1H-BENZIMIDAZOL-2-YL(1H-PYRROL-2-YL)METHANONE FORMUL 2 4AU C12 H9 N3 O FORMUL 3 HOH *86(H2 O) HELIX 1 1 SER A 57 THR A 70 1 14 HELIX 2 2 LEU A 105 VAL A 112 1 8 HELIX 3 3 PRO A 118 HIS A 139 1 22 HELIX 4 4 LYS A 147 GLN A 149 5 3 HELIX 5 5 ALA A 187 LEU A 192 1 6 HELIX 6 6 THR A 198 ARG A 215 1 18 HELIX 7 7 SER A 223 GLY A 236 1 14 HELIX 8 8 GLY A 239 TRP A 243 5 5 HELIX 9 9 PRO A 250 PHE A 254 5 5 HELIX 10 10 PRO A 261 PHE A 265 5 5 HELIX 11 11 ASP A 270 LEU A 281 1 12 HELIX 12 12 SER A 290 HIS A 297 1 8 HELIX 13 13 PRO A 298 GLN A 301 5 4 SHEET 1 AA 5 TYR A 13 GLU A 21 0 SHEET 2 AA 5 LYS A 26 ASP A 32 -1 O VAL A 27 N ILE A 19 SHEET 3 AA 5 ARG A 38 LYS A 43 -1 O ARG A 38 N ASP A 32 SHEET 4 AA 5 THR A 95 GLU A 99 -1 O LEU A 96 N LYS A 43 SHEET 5 AA 5 LEU A 79 CYS A 83 -1 N PHE A 80 O VAL A 97 SHEET 1 AB 3 GLN A 103 ASP A 104 0 SHEET 2 AB 3 ILE A 151 VAL A 153 -1 O VAL A 153 N GLN A 103 SHEET 3 AB 3 ILE A 159 LEU A 161 -1 O LYS A 160 N LEU A 152 CISPEP 1 ILE A 19 GLY A 20 0 2.70 CISPEP 2 GLY A 22 ALA A 23 0 -2.75 CISPEP 3 GLU A 114 PRO A 115 0 0.03 SITE 1 AC1 9 ILE A 19 ALA A 41 GLU A 99 HIS A 100 SITE 2 AC1 9 VAL A 101 ASP A 102 ASP A 104 LEU A 152 SITE 3 AC1 9 ALA A 162 CRYST1 100.734 100.734 60.300 90.00 90.00 90.00 I 4 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009927 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009927 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016584 0.00000